Reuters |
EU approves Sanofi and Regeneron's dupilumab in eczema
Reuters The move comes after the U.S Food and Drug Administration (FDA) regulator had also approved the injectable antibody drug in March. The product is sold as Dupixent. Atopic dermatitis is a chronic type of skin inflammation also known as eczema, which in … Sanofi's Dupixent gets Europe eczema nod Sanofi and Regeneron's Atopic Dermatitis Approved in the EU Sanofi's blockbuster-tipped Dupixent set for European launches |
